# AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

> **NCT04499118** · PHASE2 · UNKNOWN · sponsor: **Sichuan Provincial People's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- HER2-negative Breast Cancer

## Interventions

- **DRUG:** AT regimen
- **DRUG:** TP regimen

## Key facts

- **NCT ID:** NCT04499118
- **Lead sponsor:** Sichuan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08
- **Primary completion:** 2021-08
- **Final completion:** 2021-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04499118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04499118, "AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04499118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*